Back to DYN
Atlas Venture Life Science Advisors, LLC → DYN
Atlas Venture Life Science Advisors, LLC DYN Position History
Dyne Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$55.4M
Q3 2026
Peak value
$178.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $115.5M |
| Q4 2025 | $178.6M |
| Q1 2026 | $165.5M |
| Q2 2026 | $151M |
| Q3 2026 | $55.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $55.4M | 3.44M | — | — |
| Q2 2026 | $151M | 6.80M | — | — |
| Q1 2026 | $165.5M | 9.13M | — | — |
| Q4 2025 | $178.6M | 9.13M | — | — |
| Q3 2025 | $115.5M | 9.13M | — | — |
Other funds holding DYN
$269.8M
$245.6M
$245.6M
$244.3M